Identification of neoantigens derived from alternative splicing and RNA modification
The acquisition of somatic mutations is the most common event in cancer. Neoantigens expressed from genes with mutations acquired during carcinogenesis can be tumor-specific. Since the immune system recognizes tumor-specific peptides, they are potential targets for personalized neoantigen-based immu...
Saved in:
| Main Authors: | Jiyeon Park, Yeun-Jun Chung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioMed Central
2019-08-01
|
| Series: | Genomics & Informatics |
| Subjects: | |
| Online Access: | http://genominfo.org/upload/pdf/gi-2019-17-3-e23.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alternative Splicing in Tumorigenesis and Cancer Therapy
by: Huiping Chen, et al.
Published: (2025-05-01) -
Alternative splicing: A key regulator in T cell response and cancer immunotherapy
by: Caiyu Yong, et al.
Published: (2025-05-01) -
Aging-related alternative splicing drive neoantigen emergence revealed by transcriptome analysis of 1,255 human blood samples
by: Shuhan Li, et al.
Published: (2025-05-01) -
Editorial: Post-transcriptional modifications in cancer immunity and immunotherapy
by: Gaigai Wei, et al.
Published: (2025-08-01) -
Coupling of alternative splicing and alternative polyadenylation
by: Zhang Xueying, et al.
Published: (2024-12-01)